Utah Medical Products Inventory 2010-2024 | UTMD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Utah Medical Products inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Utah Medical Products inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$202.6B
Stryker (SYK)	$144.4B
Boston Scientific (BSX)	$130.4B
Medtronic (MDT)	$113.2B
EssilorLuxottica (ESLOY)	$112.1B
Lonza Group Ag (LZAGY)	$45.3B
Haleon (HLN)	$43B
GE HealthCare Technologies (GEHC)	$39B
ResMed (RMD)	$36.5B
Terumo (TRUMY)	$30.6B
Koninklijke Philips (PHG)	$24.9B
Zimmer Biomet Holdings (ZBH)	$21.8B
Insulet (PODD)	$19.3B
Baxter (BAX)	$17.5B
Smith & Nephew SNATS (SNN)	$10.8B
Bio-Rad Laboratories (BIO)	$10.2B
BellRing Brands (BRBR)	$9.2B
Demant (WILYY)	$8.4B
Lantheus Holdings (LNTH)	$5.8B
TG Therapeutics (TGTX)	$4.8B
Haemonetics (HAE)	$4.6B
ICU Medical (ICUI)	$4.4B
Prestige Consumer Healthcare (PBH)	$4B
Perrigo (PRGO)	$3.6B
Envista Holdings (NVST)	$3.6B
Neogen (NEOG)	$3.6B
Agios Pharmaceuticals (AGIO)	$3.4B
GN Store Nord (GNNDY)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B